Innovent Biologics and Sanegene Bio USA have entered a collaboration to co-develop SGB-3908, an siRNA drug candidate targeting angiotensinogen (AGT) for hypertension treatment. SGB-3908, an IND-e...
GC Biopharma, in collaboration with the Korea Disease Control and Prevention Agency (KDCA), has submitted "GC1109" for marketing approval to the Korean Ministry of Food and Drug Safety (MFDS). Th...
According to the Market Statsville Group (MSG), theGlobal Biopharmaceutical CDMO Service Marketsize is expected to grow fromUSD 100.4 billion in 2023toUSD 192.2 billion by 2033, at aCAGR of 6.7%f...
Ascentage Pharma, a global biopharmaceutical company focused on developing innovative treatments for cancer, chronic hepatitis B (CHB), and age-related diseases, has announced a significant clini...
DelNova has announced a strategic partnership with Pace® Life Sciences to serve as their contract development and manufacturing organization (CDMO). This collaboration is aimed at advancing D...
